Hua Medicine

Hua Medicine is a clinical-stage, innovative drug development company in China, focused on novel therapies for the treatment of diabetes and CNS disorders. The company has in-licensed from major pharma, world-wide rights to a potential best-in-class, oral drug for the treatment of Type 2 Diabetes which utilizes a novel mechanism of action.
Company Growth (employees)
Shanghai, CN
Size (employees)
31 (est)+11%
Hua Medicine was founded in 2010 and is headquartered in Shanghai, CN

Key People/Management at Hua Medicine

Li Chen

Li Chen

President and CEO

Hua Medicine Office Locations

Hua Medicine has offices in Shanghai and Pudong Xinqu
Pudong Xinqu, CN (HQ)
Cailun Rd
Pudong Xinqu, CN
Ai Di Sheng Lu

Hua Medicine Financials and Metrics

Summary Metrics

Founding Date


Total Funding

$125 m

Latest funding size

$50 m

Time since last funding

over 1 year


Hua Medicine's latest funding round in April 2016 was reported to be $50 m. In total, Hua Medicine has raised $125 m

Hua Medicine's Web-traffic and Trends

Hua Medicine Company Life and Culture

You may also be interested in